Benjamin List

Benjamin List
Name	Benjamin List
Birth date	1968
Birth place	Frankfurt am Main, West Germany
Nationality	German
Fields	Organic chemistry, Catalysis
Institutions	Max Planck Society; University of Marburg; Fritz Haber Institute of the Max Planck Society; Weizmann Institute of Science
Alma mater	Johannes Gutenberg University Mainz; University of Marburg
Known for	Organocatalysis; Asymmetric catalysis
Awards	Nobel Prize in Chemistry; Wolf Prize in Chemistry; Ludwig–Bölkow Prize

Benjamin List Benjamin List is a German chemist known for pioneering work in asymmetric organocatalysis and catalytic enantioselective reactions. His research established small organic molecules as catalysts for stereoselective transformations, reshaping approaches used in pharmaceutical industry, materials science, and chemical synthesis. He is director at the Max Planck Society's Institute for Coal Research and a Nobel laureate.

Early life and education

List was born in Frankfurt am Main and completed undergraduate and doctoral studies at Johannes Gutenberg University Mainz and University of Marburg, where he trained under mentors connected to research groups associated with Otto Hahn Medal-level science and institutions such as the Max Planck Society and the German Research Foundation. During his doctoral work he encountered classical methods from groups influenced by researchers at ETH Zurich, Columbia University, and California Institute of Technology, prompting interests in stereoselective methodologies exemplified by prior work from E. J. Corey, K. Barry Sharpless, and Ryōji Noyori. His early interactions included collaborations and seminars with scientists from University of Oxford, University of Cambridge, and Harvard University.

Academic and research career

List held positions at the University of Marburg and later became a director at an institute belonging to the Max Planck Society. His laboratory attracted postdocs and graduate students from institutions including Massachusetts Institute of Technology, Stanford University, University of California, Berkeley, and University of Tokyo. He developed research programs tied to consortia and networks involving European Research Council grants, collaborations with companies in the pharmaceutical industry such as BASF, Bayer, and linkages to academic centers like Weizmann Institute of Science and University of California, San Diego. He participated in conferences organized by societies such as the American Chemical Society and Royal Society of Chemistry, and served on editorial boards for journals rooted in publishers like Nature Portfolio, American Chemical Society and Wiley-VCH.

Organocatalysis and key discoveries

List is credited with establishing organocatalysis as a general strategy, demonstrating that small organic molecules—rather than enzymes or metal complexes—can catalyze asymmetric reactions. He reported seminal experiments demonstrating enamine catalysis and iminium activation enabling enantioselective aldol and Michael-type reactions, building on conceptual foundations from researchers such as Albert Eschenmoser, Gilbert Stork, Paolo Battaglini and contemporaries like David W. C. MacMillan. Key transformations developed in his group include proline-catalyzed asymmetric aldol reactions, aminocatalytic enantioselective synthesis of complex molecular scaffolds, and cascade reactions enabling rapid construction of stereogenic centers used in total syntheses of targets pursued by groups at Scripps Research Institute, California Institute of Technology, and Max Planck Institute for Coal Research. His work influenced synthetic strategies employed by teams at Pfizer, Novartis, Roche, and innovative methods developed at Duke University and Yale University.

Awards and honors

List's contributions earned top recognitions including the Nobel Prize in Chemistry (shared), the Wolf Prize in Chemistry, the Ludwig–Bölkow Prize, and prizes from organizations such as the Gottfried Wilhelm Leibniz Prize, Royal Society of Chemistry awards, and grants from the European Research Council. He received honorary degrees and fellowships from institutions including ETH Zurich, University of Oxford, University of Cambridge, and membership in academies like the German National Academy of Sciences Leopoldina and the Royal Swedish Academy of Sciences. Professional societies such as the Max Planck Society, American Chemical Society, and Royal Society recognized his impact with lectureships and named lectures.

Selected publications and contributions

Representative publications from List's group appeared in journals published by Nature Portfolio, Science (journal), Journal of the American Chemical Society, Angewandte Chemie International Edition, and Chemical Reviews (ACS). These articles described the mechanistic basis for aminocatalysis, development of asymmetric cascade reactions, and applications to the synthesis of biologically active natural products and pharmaceutical leads pursued by collaborators at Merck & Co., GlaxoSmithKline, AstraZeneca, and academic teams at University of Illinois Urbana–Champaign and New York University. His reviews have been cited alongside foundational works by E. J. Corey, K. Barry Sharpless, Ryōji Noyori, and David W. C. MacMillan, and have shaped curricula in departments at Princeton University, Imperial College London, and Seoul National University.

Personal life and outreach

List has engaged in public scientific outreach through lectures at venues including Royal Institution, Carnegie Institution for Science, and forums organized by the Alexander von Humboldt Foundation and European Molecular Biology Organization. He mentored researchers who later held positions at ETH Zurich, University of California, Berkeley, University of Cambridge, and industry leadership roles at Bayer and BASF. Outside the laboratory, he has participated in interdisciplinary initiatives connecting chemistry with policy and innovation at institutions such as the European Commission and World Economic Forum.

Category:German chemists Category:Nobel laureates in Chemistry